Literature DB >> 22925770

Synthesis of novel N-acetylneuraminic acid derivatives as substrates for rapid detection of influenza virus neuraminidase.

Wei Yang1, Xiaoyu Liu, Xiaoxia Peng, Pei Li, Tianxin Wang, Guihua Tai, X James Li, Yifa Zhou.   

Abstract

Two novel N-acetylneuraminic acid derivatives, luciferyl N-acetylneuraminic acid (1) and luciferyl 4,7-di-O-methyl-N-acetylneuraminic acid (2), were designed and synthesized as substrates for the rapid detection of influenza virus neuraminidase. The sensitivity and specificity of the assays with compound 1 or 2 as the substrate for detection of neuraminidases from influenza virus (H1N1 and H5N1) and bacteria (A. ureafaciens and C. perfringens) were evaluated. Compound 1 was sensitive to neuraminidases from both influenza virus and bacteria. Bioluminescent assays with this compound with H1N1 and H5N1 neuraminidases were approximately 20- and 16-fold more sensitive, respectively, than the fluorescent method with the commercial substrate 4-MUNANA. In contrast, compound 2 was only sensitive to the neuraminidases from influenza virus, showing approximately 10- and 8-fold greater sensitivity than 4-MUNANA for the detection of H1N1 and H5N1 neuraminidases, respectively. The data showed that compound 2 could be used in assays for detection of an influenza viral neuraminidase.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22925770      PMCID: PMC3429878          DOI: 10.1016/j.carres.2012.06.009

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  30 in total

1.  Clinical evaluation of the ZstatFlu-II test: a chemiluminescent rapid diagnostic test for influenza virus.

Authors:  Marilyn S Hamilton; David M Abel; Yolanda J Ballam; Mary K Otto; Angela F Nickell; Lisa M Pence; James R Appleman; Craig D Shimasaki; Komandoor E Achyuthan
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

2.  A new ultrasensitive bioluminogenic enzyme substrate for beta-galactosidase.

Authors:  R Geiger; E Schneider; K Wallenfels; W Miska
Journal:  Biol Chem Hoppe Seyler       Date:  1992-12

3.  Applications of a duplex reverse transcription polymerase chain reaction and direct immunofluorescence assay in comparison with virus isolation for detection of influenza A and B.

Authors:  Emerson Carraro; Daniel Ferreira Neto; Daniela Benfica; Ana Helena SittaPerosa; Celso Francisco Hernandes Granato; Nancy Cristina Junqueira Bellei
Journal:  Diagn Microbiol Infect Dis       Date:  2007-01       Impact factor: 2.803

4.  Detection of novel influenza A(H1N1) virus by real-time RT-PCR.

Authors:  David M Whiley; Seweryn Bialasiewicz; Cheryl Bletchly; Cassandra E Faux; Bruce Harrower; Allan R Gould; Stephen B Lambert; Graeme R Nimmo; Michael D Nissen; Theo P Sloots
Journal:  J Clin Virol       Date:  2009-06-06       Impact factor: 3.168

5.  Inhibition of bacterial and viral sialidases by 3-fluoro-N-acetylneuraminic acid.

Authors:  T Hagiwara; I Kijima-Suda; T Ido; H Ohrui; K Tomita
Journal:  Carbohydr Res       Date:  1994-10-03       Impact factor: 2.104

Review 6.  Detection of influenza virus: traditional approaches and development of biosensors.

Authors:  Yoshihisa Amano; Quan Cheng
Journal:  Anal Bioanal Chem       Date:  2004-12-09       Impact factor: 4.142

7.  Comparison of biological and physical properties of human and animal A(H1N1) influenza viruses.

Authors:  B Fiszon; C Hannoun; A Garcia-Sastre; E Villar; J A Cabezas
Journal:  Res Virol       Date:  1989 Sep-Oct

8.  Synthesis of bromoindolyl 4,7-di-O-methyl-Neu5Ac: specificity toward influenza A and B viruses.

Authors:  A Liav; J A Hansjergen; K E Achyuthan; C D Shimasaki
Journal:  Carbohydr Res       Date:  1999-04-30       Impact factor: 2.104

9.  Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets.

Authors:  Susu Duan; David A Boltz; Patrick Seiler; Jiang Li; Karoline Bragstad; Lars P Nielsen; Richard J Webby; Robert G Webster; Elena A Govorkova
Journal:  PLoS Pathog       Date:  2010-07-29       Impact factor: 6.823

10.  Cost-effective approaches to influenza prevention and treatment.

Authors:  Michael Rothberg
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2005-04       Impact factor: 2.217

View more
  2 in total

1.  Proximity Ligation-Based Fluorogenic Imaging Agents for Neuraminidases.

Authors:  Zhizeng Gao; Andrew J Thompson; James C Paulson; Stephen G Withers
Journal:  Angew Chem Int Ed Engl       Date:  2018-09-14       Impact factor: 15.336

2.  Bioluminescence-based neuraminidase inhibition assay for monitoring influenza virus drug susceptibility in clinical specimens.

Authors:  Henju Marjuki; Vasiliy P Mishin; Katrina Sleeman; Margaret Okomo-Adhiambo; Tiffany G Sheu; Lizheng Guo; Xiyan Xu; Larisa V Gubareva
Journal:  Antimicrob Agents Chemother       Date:  2013-08-05       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.